Novel Alzheimer's Trials Evaluate Senolytics, Semaglutide, CRISPR, and More
MedPage Today,
Neurology > Alzheimer's Disease Looking ahead to 2024 and beyond: "There is so much more to be done" by Judy George, Deputy…
Neurology > Alzheimer's Disease Looking ahead to 2024 and beyond: "There is so much more to be done" by Judy George, Deputy…
Dans un article récent publié dans la revue Nature Reviews Neurologie, les chercheurs discutent de l’efficacité des thérapies…
Researchers explore the potential of tau-targeting therapies in treating Alzheimer's disease, focusing on immunotherapies and…